X-Linked Intellectual Disability-Craniofacial Dysmorphism-Epilepsy-Ophthalmoplegia-Cerebellar Atrophy Syndrome

X-linked intellectual disability-craniofacial dysmorphism-epilepsy-ophthalmoplegia-cerebellar atrophy syndrome is a very rare genetic brain disorder. Doctors now call this condition Christianson syndrome most of the time. In this condition, the brain does not develop and work in the usual way, especially parts that control learning, movement, balance, eye movements, and behavior. Children, usually boys, have severe learning disability, seizures (epilepsy), small head size, problems with balance and walking (ataxia), eye movement problems (ophthalmoplegia), and a very happy or laughing facial expression. Brain scans often show loss of tissue in the cerebellum (cerebellar atrophy) and sometimes other parts of the brain.

This syndrome is X-linked, which means the gene change sits on the X chromosome. Boys have one X chromosome, so one harmful change is enough to cause the full disease. Girls have two X chromosomes, so they may be healthy carriers or have milder symptoms. Many children show symptoms in the first year of life, with delayed milestones, trouble sitting and walking, and early-onset seizures.

X-linked intellectual disability-craniofacial dysmorphism-epilepsy-ophthalmoplegia-cerebellar atrophy syndrome is usually called Christianson syndrome. It is a very rare genetic brain condition. Children often have severe learning disability, a small head (microcephaly), seizures, problems with balance, eye movement problems, and special facial features such as a long narrow face and open mouth. Many children show a happy mood with frequent smiling and laughter, which looks a little like Angelman syndrome.

This syndrome is caused by a harmful change (mutation) in a gene called SLC9A6 on the X chromosome. The gene makes a protein called sodium/hydrogen exchanger 6 (NHE6). This protein sits on small sacs inside brain cells called endosomes and helps control acid level (pH) by swapping sodium and hydrogen ions. When SLC9A6 does not work, endosomes become too acidic, and brain cells do not move and recycle important receptors correctly, which harms brain development and function.

Because the gene is on the X chromosome, the condition has X-linked inheritance. Boys have only one X chromosome, so one faulty copy is enough to cause the full syndrome. Girls have two X chromosomes, so they may be healthy, have mild learning problems, or rarely have more obvious symptoms, depending on how their X chromosomes are switched on in different cells. A mother who carries the change has a 50% chance to pass it to each child.

The main gene linked to this syndrome is SLC9A6, which gives the instructions to make a protein called NHE6 (Na⁺/H⁺ exchanger 6). This protein helps control the acid–base balance inside small fluid-filled sacs in cells called endosomes. When SLC9A6 is not working, the endosomes become too acidic, and nerve cells in the brain cannot grow, connect, and survive normally. This leads to intellectual disability, seizures, movement problems, and the other features of Christianson syndrome.


Other names

This same disorder appears in the medical literature under many different names. These are not different diseases. They are different names or “types” for the same SLC9A6-related syndrome:

  • Christianson syndrome

  • X-linked Angelman-like syndrome

  • X-linked intellectual disability-craniofacial dysmorphism-epilepsy-ophthalmoplegia-cerebellar atrophy syndrome

  • X-linked intellectual disability, South African type

  • Mental retardation, X-linked, syndromic, Christianson type (older term; “mental retardation” is no longer used)

  • Mental retardation, microcephaly, epilepsy, and ataxia syndrome (older term)

  • MRXSCH (abbreviation used in some genetic databases)

  • Christianson type of X-linked syndromic intellectual developmental disorder

  • Intellectual developmental disorder, X-linked, syndromic, Christianson type

  • SLC9A6-related syndromic intellectual disability

Doctors prefer the term Christianson syndrome or SLC9A6-related syndrome today, because they are shorter and less stigmatizing. However, when searching the literature, all of these names can point to the same condition.


Causes

1. Pathogenic variants in the SLC9A6 gene
The main cause is a harmful change, called a pathogenic variant or mutation, in the SLC9A6 gene on the X chromosome. This gene normally makes the NHE6 protein, which helps control the acidity inside endosomes in brain cells. When the gene is damaged, the protein does not work, and brain cells cannot handle normal cell traffic and signaling, which leads to the clinical syndrome.

2. Loss-of-function mutations
Most reported changes in SLC9A6 are “loss-of-function” mutations, such as nonsense, frameshift, or splice-site variants. These changes stop the cell from making a full, working NHE6 protein. Without this protein, internal cell compartments become too acidic, damaging developing neurons and leading to severe intellectual disability, seizures, and movement problems.

3. Missense variants affecting protein activity
Some SLC9A6 variants are missense changes, where one amino acid in the protein is swapped for another. Even though the protein is made, its transport function can be reduced or changed. This still disrupts the endosomal pH and cellular trafficking and can cause a Christianson-like clinical picture, sometimes with slightly different severity between patients.

4. X-linked inheritance from a carrier mother
In many families, boys inherit the SLC9A6 mutation from their mother, who carries the change on one of her X chromosomes. She may have mild learning problems or may be completely unaffected because her second X chromosome has a normal copy of the gene. A carrier mother has a 50% chance of passing the mutation to each child.

5. De novo (new) mutations in SLC9A6
In some children, the SLC9A6 mutation is de novo, which means it appears for the first time in that child and is not present in either parent’s blood DNA. This happens when a random error occurs during the formation of sperm or egg cells or very early in the embryo. The result is the same clinical syndrome, even without a family history.

6. Endosomal–lysosomal pH imbalance
NHE6 sits in endosomal membranes and helps remove acid (protons) in exchange for sodium ions. When SLC9A6 is mutated, endosomes become too acidic. This abnormal pH harms how cells recycle and sort proteins and receptors, especially in neurons. Over time, this leads to problems in brain connectivity and neurodegeneration.

7. Impaired synapse development and plasticity
Healthy brain development depends on forming and pruning synapses (connections) between neurons. Studies in animal models with Slc9a6 loss show altered endosomal function at synapses and abnormal synapse structure. These changes likely contribute to learning disability, absent speech, and atypical behavior in Christianson syndrome.

8. Neuronal cell loss and cerebellar atrophy
Because endosomal function is disturbed, some neurons in the cerebellum and other brain regions may die earlier or fail to grow properly. Brain imaging in patients often shows cerebellar atrophy and sometimes cortical atrophy, which match the clinical signs of ataxia and developmental delay.

9. Abnormal ocular motor pathway development
SLC9A6 is expressed in brainstem and cerebellar circuits that control eye movements. Damage in these areas during development can cause ophthalmoplegia (reduced eye movement), abnormal eye tracking, and nystagmus. These eye movement problems are described in the original South African family and later reports.

10. Disrupted cerebellar circuits for balance and gait
The cerebellum helps coordinate posture and movement. In Christianson syndrome, cerebellar atrophy and abnormal cerebellar connections lead to truncal ataxia, unsteady gait, and motor incoordination. These features are very common and are part of the core description of the disorder.

11. Early-onset epileptic networks
Abnormal brain development and neuron connectivity increase the risk of epilepsy. Children with Christianson syndrome often show seizures starting in infancy or early childhood. The underlying gene defect does not directly cause seizures in one spot, but it sets up a brain network that is highly excitable and prone to epileptic activity.

12. Xq26–Xq27 chromosomal location vulnerability
The SLC9A6 gene lies in the Xq26–Xq27 region. Early linkage studies in large families with severe X-linked intellectual disability, epilepsy, ophthalmoplegia, and cerebellar atrophy mapped the condition to this region before the exact gene was identified. This area appears to be a hotspot for mutations affecting brain development.

13. Possible skewed X-inactivation in carrier females
In females, one X chromosome in each cell is randomly switched off (X-inactivation). If the X chromosome with the normal SLC9A6 copy is more often inactivated, a female carrier may show learning difficulties or mild neurological symptoms. Thus, the same gene mutation can cause different levels of symptoms depending on X-inactivation patterns.

14. Interaction with autism spectrum disorder biology
Some individuals with SLC9A6 mutations also meet criteria for autism spectrum disorder, suggesting that disturbed endosomal trafficking and synaptic function overlap with pathways involved in autism. This means the gene defect may contribute both to global developmental delay and to atypical social communication and behavior.

15. Interaction with other genetic modifiers
Different families with SLC9A6 mutations can have different severity, even with similar types of variants. This suggests that other genes, sometimes called modifier genes, may make the clinical picture milder or more severe. These modifiers do not cause the syndrome on their own but can influence how strongly the SLC9A6 defect shows.

16. Possible effects of somatic mosaicism
In rare cases, a mutation may be present in only some of the body’s cells (mosaicism). If a parent has mosaicism for an SLC9A6 mutation in their germ cells, they may have no symptoms but still have more than one affected child. This mechanism can explain some seemingly “sporadic” or unusual inheritance patterns.

17. General genetic disease mechanisms (DNA replication errors)
Like many single-gene disorders, Christianson syndrome ultimately arises from small errors when DNA is copied in reproductive cells or early embryos. These errors are usually random and not due to anything the parents did or did not do. They are part of the baseline risk of genetic variation in all humans.

18. Lack of NHE6 function in non-brain tissues
Although the main problems are neurological, SLC9A6 is also expressed in other tissues. Abnormal NHE6 function may contribute to feeding difficulties, reflux, or poor growth by affecting cells in the gut or other organs, adding to the overall clinical picture.

19. Overlap with X-linked cerebellar dysgenesis group
Christianson syndrome belongs to a broader group of X-linked disorders with cerebellar defects, which share pathways controlling cerebellar development. Disruption of these shared pathways by SLC9A6 mutations may help explain why cerebellar atrophy is such a central feature.

20. Overlap with X-linked intellectual disability syndromes with seizures
The syndrome also fits within the large group of X-linked intellectual disability disorders where seizures are common. Many genes on the X chromosome are important for brain excitability and synapse stability, so damage to SLC9A6 interacts with these broader X-linked brain pathways, increasing the chance of epilepsy.


Symptoms

1. Intellectual disability and developmental delay
Children with this syndrome usually have moderate to profound intellectual disability. They learn to sit, stand, walk, and communicate much later than other children, and many never develop spoken language. They may understand some simple words or gestures but need lifelong support for daily activities and learning.

2. Absent or very limited speech
A striking sign is that many affected boys remain nonverbal or have only a few words. They may use sounds, facial expressions, or gestures instead of speech. This severe speech delay reflects both global developmental delay and specific problems with brain areas that control language and mouth movements.

3. Microcephaly (small head size)
Many children develop postnatal microcephaly, which means their head grows more slowly than expected after birth. Doctors can see this when head circumference measurements fall below the normal curve. Microcephaly is a sign that the brain is smaller than usual, and it matches the imaging finding of brain and cerebellar atrophy.

4. Seizures (epilepsy)
Seizures are very common and often begin in infancy or early childhood. Seizure types can vary, including generalized seizures (affecting the whole brain) and sometimes other patterns. Seizures can be frequent and may be hard to control, which can further affect development and quality of life.

5. Cerebellar ataxia and unsteady gait
Because the cerebellum is affected, children often have truncal ataxia, which is trouble keeping the body steady when sitting or walking. They may sway, fall easily, or walk with a wide-based, unsteady gait. Some need support, walkers, or wheelchairs, especially as they grow.

6. Ophthalmoplegia and abnormal eye movements
Many patients have difficulty moving their eyes normally. This can appear as ophthalmoplegia (partly paralyzed eye muscles), jerky eye movements, or trouble looking up or sideways. Eye movement problems can make it hard to fix gaze or follow objects and may contribute to problems with balance.

7. Distinct craniofacial appearance
Children often have a long, narrow face, prominent nose and jaw, and large ears. The mouth may stay open, with frequent drooling. These craniofacial features, together with the happy facial expression, helped doctors recognize the original families and are still useful clues for the diagnosis.

8. Happy demeanor and frequent laughter
A well-known feature is a happy, smiling appearance with spontaneous laughter that may not match the situation. This “Angelman-like” behavior is one reason the condition was first thought to be a form of Angelman syndrome. It can be pleasant for families but may also mask the child’s difficulties.

9. Hypotonia and poor muscle tone
Many babies show hypotonia, which means low muscle tone. They may feel “floppy” when held and have trouble lifting their head, rolling, or sitting. Hypotonia contributes to delayed motor milestones and can lead to joint laxity and difficulties with posture.

10. Feeding difficulties and failure to thrive
Feeding problems are common, especially in infancy. Babies may have weak sucking, trouble coordinating sucking and swallowing, or frequent vomiting due to reflux. Because of these issues, some children gain weight poorly and may be described as having “failure to thrive.” Tube feeding may be needed in severe cases.

11. Gastroesophageal reflux and drooling
Many children have acid reflux from the stomach into the esophagus, causing discomfort, coughing, or vomiting. At the same time, poor mouth control can cause chronic drooling. Both problems may irritate the skin around the mouth and chin and increase the risk of chest infections from aspiration.

12. Motor stereotypies and hyperactive movements
Repetitive movements, such as hand-flapping, body rocking, or other stereotyped actions, are common. Children may also show hyperkinesis, meaning they move a lot and have trouble staying still. These behaviors overlap with features of autism spectrum disorder and other neurodevelopmental conditions.

13. Developmental regression in some children
Some children lose skills they had gained earlier, such as words, motor abilities, or social responses. This developmental regression can happen in early childhood and may be related to epilepsy or progressive brain changes. It can be very distressing for families and often prompts further testing.

14. Behavioral and autism-like features
Many individuals show features of autism, such as reduced eye contact, difficulty with social interaction, and repetitive behaviors. They may also have attention problems and irritability. This overlap with autism spectrum disorder is now well recognized in SLC9A6-related conditions.

15. Other neurological signs (spasticity, abnormal movements)
Some children develop increased muscle stiffness (spasticity), abnormal involuntary movements, or other neurological signs as they get older. These signs reflect the widespread effect of the gene defect on different parts of the brain and can add to mobility and care needs.


Diagnostic tests

In real life, doctors choose tests based on the child’s symptoms and local resources. Not every child needs every test below. The main goal is to confirm the SLC9A6 mutation and to understand how the brain and body are affected.

Physical-exam–based tests

1. Detailed general physical examination
The doctor first does a full physical exam. They check growth (weight, height, head size), facial shape, body proportions, skin, joints, and organs. In Christianson syndrome, they may see microcephaly, long narrow face, large ears, open mouth, drooling, and low or high muscle tone, which together point toward a syndromic condition rather than isolated developmental delay.

2. Neurological examination
A careful neurological exam looks at muscle tone, reflexes, strength, coordination, eye movements, and gait. In this syndrome, doctors often find hypotonia or later spasticity, truncal ataxia, abnormal eye movements, and sometimes joint laxity. These findings help decide which brain regions are involved and guide further imaging and tests.

3. Developmental assessment in clinic
During the visit, the doctor or therapist watches how the child sits, crawls, walks, uses hands, and interacts socially. They also ask about language, play, and daily skills. In Christianson syndrome, global delay and absent speech stand out, and this clinical picture supports ordering genetic tests for syndromic intellectual disability.

4. Eye movement and cranial nerve examination
An eye doctor or neurologist examines eye movements in all directions, checks for nystagmus, and tests other cranial nerves such as facial movement and swallowing. Ophthalmoplegia, abnormal tracking, or other cranial nerve signs raise suspicion of a brainstem or cerebellar process, fitting the Christianson syndrome picture.

Manual and functional tests

5. Standardized developmental scales
Tools like the Bayley Scales of Infant Development or similar tests measure motor, language, and cognitive functioning using age-based tasks. Children with Christianson syndrome usually score well below age expectations in all domains, confirming the degree of developmental delay and helping track progress over time.

6. Speech and language evaluation
A speech-language pathologist reviews the child’s ability to make sounds, understand words, and communicate with gestures or devices. In this syndrome, many children are nonverbal, so the evaluation often focuses on alternative ways to communicate, such as picture boards or communication devices.

7. Occupational therapy and motor skills testing
Occupational and physical therapists use simple tasks to assess fine motor skills, hand use, posture, and coordination. They may notice poor trunk control, unsteady sitting, weak grasp, and problems with everyday tasks like feeding or dressing, consistent with cerebellar ataxia and hypotonia.

8. Behavioral and autism screening tools
Questionnaires and structured tools, such as autism screening checklists, help identify social communication difficulties and repetitive behaviors. Many individuals with SLC9A6-related syndrome meet criteria for autism, so these tools support planning therapies and services.

Laboratory and pathological tests

9. Basic blood and metabolic tests
At first, doctors often order standard blood tests (full blood count, electrolytes, liver and kidney tests) and basic metabolic screens to rule out other treatable causes of developmental delay and seizures. In Christianson syndrome these tests are usually normal, but they help exclude metabolic diseases that can look similar.

10. Chromosomal microarray (CMA)
A chromosomal microarray looks for small missing or extra pieces of chromosomes (copy-number variants). It may detect a deletion that removes part or all of SLC9A6 or other genes in the region. Sometimes CMA is the first test that suggests an X-linked disorder affecting the Xq26–Xq27 region.

11. Single-gene sequencing of SLC9A6
If Christianson syndrome is suspected, doctors can order sequencing of the SLC9A6 gene. This test reads the gene’s DNA letters and looks for point mutations or small insertions/deletions. Finding a pathogenic variant confirms the diagnosis and allows testing of parents and siblings for carrier status.

12. Multi-gene panels for epileptic encephalopathy or intellectual disability
In many centers, instead of testing a single gene, doctors use a multi-gene panel that includes SLC9A6 along with many other genes linked to seizures and developmental delay. This can be faster and more cost-effective, especially when the clinical picture is not fully typical.

13. Whole-exome sequencing (WES)
Whole-exome sequencing reads nearly all coding genes at once. In children with unexplained early-onset seizures and developmental delay, WES has identified new SLC9A6 mutations, including de novo frameshift variants. This powerful tool is especially helpful when earlier targeted tests were negative.

Electrodiagnostic tests

14. Electroencephalogram (EEG)
An EEG records the brain’s electrical activity using electrodes on the scalp. In Christianson syndrome, EEG often shows patterns of epileptic activity that match the child’s seizures, sometimes with features of epileptic encephalopathy. EEG helps classify seizure type and guide anti-seizure medication choices.

15. Video-EEG monitoring
In some cases, prolonged video-EEG is used to capture frequent or unclear events. This allows doctors to match seizure movements with EEG changes. In children with complex episodes and developmental regression, video-EEG can show how often seizures are happening and whether treatments are helping.

Imaging tests

16. Brain MRI (magnetic resonance imaging)
MRI is the key imaging test in this syndrome. It typically shows cerebellar atrophy and sometimes cortical and brainstem atrophy. These findings, combined with the clinical picture and X-linked inheritance, strongly suggest Christianson syndrome and support genetic testing for SLC9A6 mutations.

17. Follow-up MRI to track progression
Repeat MRI scans over time can show whether cerebellar and cortical atrophy are progressing. In some children, the cerebellum becomes more atrophic as they age. Watching this pattern helps doctors understand the natural history and can guide counseling about long-term expectations.

18. CT scan of the brain (when MRI is not available)
If MRI is not possible, a CT scan may show generalized brain atrophy or enlarged fluid spaces (ventricles). CT is less detailed than MRI and less sensitive for cerebellar changes, but it can still provide useful information in resource-limited settings or emergencies.

19. Structural and functional eye imaging
Although not always used, eye doctors may perform imaging of the retina or optic nerve if there are concerns about visual function. Christianson syndrome is mainly a brain disorder, but some patients may have visual tracking problems or optic issues, and documenting these helps with rehabilitation planning.

20. Spine and orthopedic imaging (when indicated)
Some children develop scoliosis or other orthopedic problems due to hypotonia, ataxia, or muscle imbalance. X-rays or other imaging of the spine and limbs can help plan physical therapy, braces, or surgery if needed. These tests do not diagnose the syndrome itself but evaluate complications linked to the movement disorder.

Non-pharmacological treatments

These approaches do not replace medicine for seizures or other problems, but they are essential for quality of life. Evidence from Christianson syndrome and other intellectual disability and epilepsy conditions shows that early, intensive, family-centred therapies can improve function and prevent complications.

  1. Early intervention programs
    Early intervention means starting support in the first years of life, as soon as delays are seen. A team (developmental paediatrician, therapists, teachers) helps parents learn activities to stimulate movement, language, play, and thinking skills at home. This early, structured play and learning can improve developmental progress and may reduce secondary problems such as contractures or behavioural difficulties.

  2. Physical therapy (physiotherapy)
    A physiotherapist uses exercises, stretching, and play to improve strength, posture, and balance. For Christianson syndrome, physical therapy focuses on sitting balance, standing, walking, and preventing joint stiffness, scoliosis, and hip dislocation. Simple home programs, standing frames, and walkers can help the child stay as mobile and comfortable as possible over time.

  3. Occupational therapy
    Occupational therapists help with daily skills such as feeding, dressing, play, and hand use. In this syndrome, occupational therapy works on grasping, reaching, and using adapted cups, spoons, and switches. The goal is to make the child more independent and to reduce caregiver burden using special chairs, splints, and other adaptive equipment.

  4. Speech and communication therapy
    Many children with Christianson syndrome never develop spoken sentences, but speech therapists can teach augmentative and alternative communication (AAC), such as picture boards, sign language, or communication devices. This reduces frustration, helps the child express pain and needs, and improves social interaction with family and school.

  5. Behavioural and autism-focused therapy
    Some children show autistic features, repetitive movements, or challenging behaviour. Behavioural therapies, including positive behaviour support and autism-informed programs, help parents understand triggers and build routines that reduce meltdowns, self-injury, and sleep problems. Simple visual schedules and predictable daily plans are often helpful.

  6. Special education and individualized education plans (IEPs)
    Most children need special education with an individualized plan. Teachers adapt learning goals to the child’s level, focus on functional skills, and use smaller steps and repeated practice. The plan may include one-to-one support, classroom aids, and therapies delivered during school hours to maximise learning time.

  7. Seizure first-aid training and safety planning
    Families, teachers, and caregivers should be trained in seizure first aid: keeping the child safe during a seizure, timing events, and knowing when to call emergency services. Safety planning includes padded furniture edges, supervised bathing, and avoiding high-risk activities alone, reducing injury and fear when seizures occur.

  8. Feeding and swallowing (dysphagia) therapy
    Many children have poor chewing, choking, or reflux. A speech or occupational therapist with feeding expertise can assess swallowing, suggest safer food textures, and teach positions that reduce aspiration risk. Early feeding therapy lowers the chance of pneumonia and improves weight gain and comfort with eating.

  9. Nutritional counselling
    A dietitian can design diets that maintain a healthy weight, prevent constipation and reflux, and, where appropriate, support a ketogenic or modified Atkins diet for hard-to-control seizures. Careful monitoring ensures enough calories, protein, vitamins, and minerals while respecting cultural food habits.

  10. Orthotic devices and positioning equipment
    Braces, ankle-foot orthoses, standing frames, special seating systems, and sleep positioning devices help keep joints in good alignment and reduce contractures and pain. These tools support safe standing and walking and make daily care like bathing and feeding easier for caregivers.

  11. Ophthalmology care and vision therapy
    Regular review by an eye specialist is important for strabismus, ophthalmoplegia, or cataract. Glasses, patching, or eye muscle exercises may improve functional vision. In some cases, surgery is considered (discussed under surgeries), but ongoing visual rehabilitation also helps the child use remaining vision well.

  12. Postural management and seating
    Special chairs with head and trunk supports, tilt-in-space wheelchairs, and safe lying systems help prevent scoliosis, hip problems, and pressure sores. Good posture also improves breathing, swallowing, and comfort, and lets the child join family activities and school more easily.

  13. Respiratory physiotherapy
    Some children have weak cough, drooling, or recurrent chest infections. Chest physiotherapy, assisted coughing techniques, suctioning when needed, and positioning to keep the airway clear can reduce lung infections and hospital stays. Families are taught simple home methods to manage mucus and breathing problems early.

  14. Sleep hygiene and behavioural sleep support
    Sleep disturbance is common in neurodevelopmental disorders. Calm bedtime routines, fixed sleep and wake times, reducing screens before bed, and using dim light and quiet spaces can improve sleep. Behaviour therapists can help manage nighttime waking and teach strategies that fit the family’s culture and home situation.

  15. Psychological support for parents and siblings
    Caring for a child with severe disability and epilepsy is stressful. Counselling, parent support groups, and respite services reduce burnout and depression in caregivers. Better caregiver mental health is linked with more consistent therapy at home and better outcomes for the child.

  16. Genetic counselling
    A genetic counsellor explains the cause, inheritance pattern, and recurrence risks for future pregnancies. They discuss options such as carrier testing, prenatal diagnosis, or pre-implantation genetic testing for families who wish to use them, and also provide emotional support around these difficult decisions.

  17. Assistive communication and computer technology
    Tablets with communication apps, eye-gaze devices, switches, and adapted keyboards allow children to participate in school, play, and family decisions even if they do not speak. This improves independence, social connection, and self-esteem.

  18. Environmental modifications at home and school
    Simple changes such as ramps, grab bars, non-slip floors, safe play spaces, and visual labels on rooms and objects make daily life safer and more understandable. These changes reduce falls, prevent injuries during seizures, and support learning in a familiar environment.

  19. Dental and oral care programs
    Drooling, open-mouth posture, and difficulty brushing teeth increase risk of dental decay and gum disease. Regular dental visits, fluoride treatments, and daily assisted brushing help protect teeth, which is important for comfort, nutrition, and preventing infections that can worsen overall health.

  20. Community inclusion and social skills support
    Day programs, adapted sports, music therapy, and community groups help children and adults with Christianson syndrome join society rather than stay isolated at home. Social participation protects mental health, supports caregivers, and promotes dignity and quality of life.


Drug treatments

There is no cure for this syndrome yet. Medicines are used mainly to control seizures, reflux, constipation, sleep problems, and other symptoms. Drug choice and dose must always be made by a neurologist or other specialist, based on the child’s age, seizure type, and health.

Below, doses are general ranges from FDA labels for epilepsy; exact dosing and timing must be set by the treating doctor.

  1. Levetiracetam (Keppra / Keppra XR) – Antiseizure drug. Often used as first-line or add-on therapy for focal and generalized seizures. Typical pediatric doses may start around 10–20 mg/kg twice daily and increase as needed. It works by modulating synaptic neurotransmitter release. Side effects can include irritability, sleep changes, and, rarely, mood problems.

  2. Valproic acid / valproate (Depakene, Depacon, Depakote) – Broad-spectrum antiseizure medication. It is useful for generalized seizures and epileptic encephalopathies but must be used with great care because of liver, pancreas, and pregnancy-related risks. Doses are often in the range of 10–60 mg/kg/day divided. Side effects include weight gain, tremor, hair loss, and serious liver or pancreatic toxicity in some patients.

  3. Lamotrigine (Lamictal / Lamictal XR) – Antiseizure drug used as adjunctive or monotherapy for focal and generalized tonic–clonic seizures. It is titrated very slowly to lower the risk of serious skin rash. It works on sodium channels and glutamate release. Side effects can include dizziness, rash, and rarely life-threatening skin reactions.

  4. Clonazepam (Klonopin) – Benzodiazepine antiseizure and anti-myoclonic drug. It enhances GABA (inhibitory) signalling to calm brain activity. It can help myoclonic or generalized seizures but may cause drowsiness, drooling, and tolerance over time. It is usually used as an add-on medicine at the lowest effective dose.

  5. Topiramate – Broad-spectrum antiseizure medicine that also helps with some behavioural and mood symptoms in certain patients. It works on sodium channels, GABA, and glutamate receptors. Side effects may include weight loss, slowed thinking, kidney stones, and metabolic acidosis, so monitoring is needed.

  6. Rufinamide – Antiseizure drug sometimes used in epileptic encephalopathies and Lennox–Gastaut syndrome, which share features with severe epilepsies seen in Christianson syndrome. It modifies sodium channel inactivation. Nausea, dizziness, and fatigue are possible side effects.

  7. Clobazam – Benzodiazepine approved for seizures in Lennox–Gastaut syndrome. It can reduce drop attacks and other seizures. It binds to GABA-A receptors. Side effects are similar to other benzodiazepines: sleepiness, drooling, and potential dependence with long-term use.

  8. Carbamazepine – Sodium channel blocking antiseizure drug used mainly for focal seizures. It is not ideal for some generalized epilepsies but can help selected patients. Side effects may include low sodium, dizziness, rash, and blood count changes, so blood tests are needed.

  9. Oxcarbazepine – Related to carbamazepine, used for focal seizures with a somewhat different side-effect profile. It also blocks sodium channels. Hyponatremia (low sodium) is relatively common, so doctors monitor electrolytes, especially in children taking other medicines.

  10. Lacosamide – Add-on therapy for focal seizures in older children and adults. It enhances slow inactivation of sodium channels, stabilizing brain electrical activity. Dizziness and heart rhythm changes are possible, so it is usually used under specialist guidance for difficult-to-control seizures.

  11. Zonisamide – Broad-spectrum antiseizure drug that affects sodium and calcium channels and carbonic anhydrase. It may help when other medicines fail. Side effects include loss of appetite, kidney stones, and metabolic acidosis, so monitoring of weight and blood tests is important.

  12. Phenobarbital – Older antiseizure barbiturate sometimes used in infants or when other options are limited. It increases GABA activity. Long-term use can cause sedation, behavioural problems, and effects on thinking, so many clinicians prefer newer drugs if possible.

  13. Diazepam (oral / rectal) as rescue medicine
    Diazepam can be given as a rescue medicine for prolonged seizures or seizure clusters. It is a benzodiazepine that quickly boosts GABA activity to stop seizures. Rectal gels or oral solutions are often used at home, with clear instructions from the neurologist on when and how to use them.

  14. Midazolam (buccal / intranasal) as rescue medicine
    Midazolam is another benzodiazepine used in emergency seizure plans. Buccal or nasal forms can stop seizures quickly outside the hospital. Families are trained on using the correct dose and calling emergency services if seizures continue.

  15. Baclofen (oral)
    Some people have increased muscle tone or spasticity. Baclofen is a muscle relaxant that acts on GABA-B receptors in the spinal cord, reducing stiffness and spasms. It can improve comfort and mobility but may cause drowsiness and weakness, so doses are increased slowly.

  16. Proton pump inhibitors (e.g., omeprazole)
    For significant gastroesophageal reflux, proton pump inhibitors can reduce stomach acid, protect the esophagus, and ease pain. They work by blocking the final step of acid production in stomach cells. Long-term use needs medical review because of possible effects on nutrient absorption.

  17. Laxatives (e.g., polyethylene glycol)
    Constipation is common due to low mobility and medicines. Osmotic laxatives such as polyethylene glycol draw water into the stool, making it softer and easier to pass. Regular bowel plans reduce pain, behaviour issues, and risk of impaction.

  18. Melatonin
    Melatonin is a hormone that helps control sleep–wake cycles. Supplemental melatonin, usually given in the evening, can help some children with neurodevelopmental disorders fall asleep easier and stay asleep longer, when combined with good sleep habits. Dosage and safety should be checked with a doctor.

  19. Selective serotonin reuptake inhibitors (SSRIs)
    Some adolescents or adults with Christianson syndrome develop anxiety or mood symptoms. Low-dose SSRIs may be considered under psychiatric care to improve mood and reduce anxiety. These medicines increase serotonin levels in the brain but require careful monitoring for side effects.

  20. Antipsychotic medicines (e.g., risperidone) in selected cases
    For severe aggression or self-injury that does not respond to behavioural support, low-dose atypical antipsychotics may be used short-term under specialist supervision. They affect dopamine and serotonin receptors. Because of risks such as weight gain and movement disorders, they are usually considered only when absolutely necessary.


Dietary molecular supplements

Scientific evidence for specific supplements in Christianson syndrome is limited, so these should only be used with medical advice, often to correct deficiencies or support overall health.

  1. Omega-3 fatty acids (fish oil / algal oil) – Often 250–500 mg EPA+DHA daily for children, adjusted by the doctor. Omega-3s support brain cell membranes and may help mood and inflammation. They may modestly support cognitive and behavioural health in some neurodevelopmental disorders.

  2. Vitamin D – Dose depends on blood levels and age. Vitamin D supports bone health, immune function, and muscle strength, which is important for children with limited mobility and antiseizure drugs that affect bone density. Levels are tested and supplements given to keep them in the normal range.

  3. Calcium – Provided mainly through diet or, when needed, supplements. Calcium works with vitamin D to keep bones strong, especially important in children who are thin, have osteoporosis, or use medicines that weaken bones. Dose is planned by the doctor and dietitian.

  4. Vitamin B6 (pyridoxine) – Low doses may support general nervous system function and help in some seizure types, although true pyridoxine-dependent epilepsy is different and rare. Excess B6 can harm nerves, so any supplement must be supervised.

  5. Folate and vitamin B12 – These vitamins help make DNA and red blood cells. Correcting low folate or B12 can improve energy and prevent anemia, which indirectly supports brain function. Routine blood tests guide whether supplements are needed.

  6. Magnesium – Magnesium is involved in nerve signalling and muscle relaxation. It may help with constipation and muscle cramps. Too much can cause diarrhea or affect the heart, so dose is usually modest and checked by the doctor.

  7. Coenzyme Q10 – A mitochondrial cofactor that helps cells make energy. In some neurological conditions, CoQ10 is used to support cell energy production, though evidence is limited. Doctors may consider it if there are signs of mitochondrial dysfunction.

  8. L-carnitine – Helps shuttle fatty acids into mitochondria. It is sometimes used when valproate is given or when blood levels are low, to protect the liver and improve energy. Dosing and monitoring must follow specialist advice.

  9. Probiotics – Beneficial bacteria may help with constipation, diarrhea, and general gut health, which is often disturbed by medicines and limited diets. They are chosen carefully, especially in children with weakened immune systems.

  10. Medium-chain triglyceride (MCT) oil – Sometimes used as part of ketogenic or modified diets for difficult seizures. MCTs provide an alternative fuel (ketones) for the brain. Because ketogenic diets are medical therapies, they should be planned and monitored by an experienced dietitian and neurologist.


Regenerative, immunity-related, and stem-cell-focused approaches

At present, no regenerative or stem cell drug is approved specifically for Christianson syndrome. Research is exploring future options; these should only be used in clinical trials.

  1. Gene therapy targeting SLC9A6 – Experimental work is exploring ways to deliver a working SLC9A6 gene or correct the mutation using viral vectors or gene-editing methods. The idea is to restore NHE6 function and normal endosome pH in neurons. This is still at research stage, not a standard treatment.

  2. Neurotrophic factor–based therapies – Studies show that NHE6 affects brain growth factor signalling (such as TrkB and BDNF). Future drugs might boost these pathways to support synapse development and plasticity. So far, this remains a laboratory concept rather than a routine clinical therapy.

  3. Small molecules that normalise endosome pH – Because SLC9A6 loss leads to over-acidic endosomes, drugs that adjust endosome–lysosome pH or trafficking may protect neurons. Researchers are investigating such compounds in cell and animal models, but they are not yet used in people with Christianson syndrome.

  4. General immune health (vaccination and infection control) – While not a “regenerative” drug, routine vaccines and prompt treatment of infections are vital to protect fragile children from severe illness that can worsen seizures and regression. Keeping up-to-date immunisation supports overall brain and body health.

  5. Hematopoietic or mesenchymal stem cell therapy (experimental in neurodevelopmental disorders) – Stem cell infusions are being studied in some other neurological conditions, but there is no solid evidence that they help Christianson syndrome, and there may be serious risks. Such approaches should only be undertaken in ethical, regulated clinical trials.

  6. Neuroprotective strategies in trials – Trials in related epileptic encephalopathies are testing drugs that reduce excitotoxicity, oxidative stress, or inflammation in the brain. If proven safe and effective, some of these strategies might later be tried in SLC9A6-related disorders, but for now they are experimental.


Surgeries (procedures and why they are done)

Surgery does not cure the genetic cause but may treat complications.

  1. Gastrostomy tube (G-tube) placement – For children with severe swallowing problems, poor weight gain, or repeated aspiration pneumonia, a feeding tube into the stomach can provide safe nutrition and medicines, reduce mealtime stress, and lower lung infection risk.

  2. Anti-reflux surgery (e.g., Nissen fundoplication) – If reflux is very severe and not controlled with medicines, surgeons may wrap the upper stomach around the lower esophagus to reduce acid coming up. This can protect the lungs and improve comfort but is considered only after careful testing.

  3. Spinal fusion for scoliosis – Progressive scoliosis can cause pain, difficulty sitting, and breathing problems. Spinal fusion uses rods and bone grafts to straighten and stabilise the spine. The goal is better sitting balance, less pain, and protection of lung function.

  4. Orthopaedic surgery for contractures or hip dislocation – Tendon lengthening or hip surgery may be needed when joint stiffness or hip problems make sitting, standing, or hygiene hard. Surgery aims to improve comfort, positioning, and care, and often works together with physiotherapy and orthotics.

  5. Strabismus (eye muscle) surgery – For severe squint that affects vision or social interaction, eye surgeons may adjust the eye muscles to improve alignment. While it does not fix underlying brain problems, it can help functional vision and eye contact.


Preventions and risk reduction

We cannot prevent the genetic change once it is present, but we can reduce complications and help the child stay as healthy as possible.

  1. Genetic counselling before future pregnancies – Helps families understand recurrence risk and options.

  2. Early diagnosis and early intervention – Starting therapies and seizure control early may lower regression and secondary problems.

  3. Good seizure management and rescue plans – Reduces status epilepticus, injuries, and hospitalisations.

  4. Routine vaccination and infection control – Protects against pneumonia, meningitis, and other serious infections.

  5. Safe feeding and early dysphagia assessment – Lowers risk of aspiration and poor growth.

  6. Regular monitoring of spine, hips, and bones – Allows early treatment of scoliosis, hip problems, and osteoporosis.

  7. Bowel management and hydration – Prevents severe constipation and related emergencies.

  8. Sleep hygiene and mental health support – Helps the whole family function better and keeps therapies consistent.

  9. Dental care and mouth hygiene – Prevents pain and infection that can worsen behaviour and feeding.

  10. Environmental safety – Home and school adapted to reduce falls, burns, drowning, and other injuries during seizures.


When to see doctors

Parents or caregivers should contact a doctor urgently or seek emergency care if seizures last more than a few minutes, come in clusters without recovery, or are different from usual seizures; if the child has breathing difficulty, blue lips, or unresponsiveness; or if there is suspected aspiration or severe infection (high fever, fast breathing, extreme sleepiness).

Regular follow-up with a neurologist, developmental paediatrician, and geneticist is important at least once or twice a year, or more often in young children. Families should also see therapists, dietitians, and social workers regularly to adjust care plans as the child grows.


What to eat and what to avoid

Food plans must always respect culture, religion, and the child’s medical needs. A dietitian can personalise these rules.

  1. Eat soft, well-cooked foods that are easy to chew and swallow; avoid hard, dry, or crumbly foods that can cause choking.

  2. Eat small, frequent meals if reflux or slow stomach emptying is present; avoid very large meals close to bedtime.

  3. Eat high-fiber foods (fruits, vegetables, whole grains) to help constipation; avoid very low-fiber diets based only on refined starches.

  4. Eat enough protein (eggs, fish, beans, lentils, meat if used) to support growth; avoid over-reliance on sugary drinks or snacks.

  5. Eat healthy fats like oils, nuts (if safe), and seeds; avoid excess trans fats and deep-fried fast foods.

  6. Ensure good hydration with water; avoid large amounts of sugary soft drinks or energy drinks.

  7. If on ketogenic or special seizure diet, follow the team’s rules closely; avoid adding extra carbohydrates that can break ketosis.

  8. Limit very salty and heavily processed foods that may worsen blood pressure and kidney load.

  9. Avoid alcohol, recreational drugs, and any herbal products not checked with the doctor, as they may interact with antiseizure medicines.

  10. Maintain vitamin and mineral intake as advised; avoid starting supplements on your own without medical advice, especially in children.


Frequently asked questions (FAQs)

  1. Is this syndrome the same as Christianson syndrome?
    Yes. The long name “X-linked intellectual disability-craniofacial dysmorphism-epilepsy-ophthalmoplegia-cerebellar atrophy syndrome” is one of several names for Christianson syndrome, all caused by damaging changes in the SLC9A6 gene.

  2. Is there a cure?
    There is no cure at present. Treatment focuses on controlling seizures, supporting feeding and breathing, and maximising development through therapies and education. Research is exploring gene and pathway-targeted treatments, but these are not yet available in routine care.

  3. Can my other children have the same condition?
    If the mother carries the SLC9A6 mutation, each son has a 50% chance to be affected and each daughter has a 50% chance to be a carrier or sometimes mildly affected. Genetic counselling and testing help clarify this risk.

  4. Will my child ever walk or talk?
    Many children learn to sit and some walk with support, but others remain wheelchair users. Most have very limited or absent spoken language, though they can still communicate using gestures, facial expression, and AAC tools. Early therapy supports whatever skills are possible for that child.

  5. Are seizures lifelong?
    Seizures usually begin early in life and can be frequent. Some individuals improve with age and treatment, while others continue to have difficult-to-control epilepsy. Regular review and adjusting medicines over time are important.

  6. Does this condition shorten life expectancy?
    Because it is rare, exact life expectancy is not well known. However, risks include severe epilepsy, aspiration pneumonia, and major infections. Good seizure control, feeding support, vaccination, and careful monitoring can reduce many of these risks.

  7. Can my child attend school?
    Yes. Many children attend special schools or mainstream schools with strong support. Individualised education plans focus on functional communication, self-care, and participation rather than standard academic goals.

  8. Is Christianson syndrome related to autism?
    Many people with SLC9A6 mutations show autistic features, such as poor social communication, repetitive movements, and sensory differences. Some research papers describe Christianson syndrome as part of the autism spectrum, but it is also a distinct genetic epilepsy and ataxia syndrome.

  9. Can MRI or other scans confirm the diagnosis?
    Brain MRI often shows cerebellar atrophy and sometimes other brain changes, but these patterns are not unique. The definite diagnosis comes from genetic testing that finds a pathogenic SLC9A6 variant.

  10. Are parents to blame for this condition?
    No. The condition is caused by a genetic change that parents cannot predict or control. Learning about the gene and inheritance can help families understand that nothing they did during pregnancy or early childhood caused the syndrome.

  11. How common is this syndrome?
    Christianson syndrome is very rare. Estimates suggest fewer than 1,000 people in the United States, and the true number worldwide is unknown, partly because many people are still undiagnosed.

  12. What doctors should be involved in care?
    Care is usually shared between a neurologist, developmental or general paediatrician, geneticist, therapists (physio, occupational, speech), dietitian, ophthalmologist, orthopaedic surgeon, dentist, and sometimes psychiatrist or psychologist. A coordinated team approach works best.

  13. Can adults with this syndrome work or live independently?
    Most people with Christianson syndrome need lifelong support with daily activities and finances. Some adults may join supported work or day programs. Quality of life can still be good with proper care, social inclusion, and respect for their preferences.

  14. Are there patient groups or communities?
    Yes. Several rare disease and SLC9A6-related syndrome organisations and online communities provide education, advocacy, and peer support for families. These groups help families share experiences and learn about research and trials.

  15. What is the most important thing families can do?
    The most important steps are: work closely with a trusted medical team, keep seizures and infections as controlled as possible, start therapies early, protect mental health of caregivers, and remember that the child is more than their diagnosis, with their own personality and strengths.

Disclaimer: Each person’s journey is unique, treatment planlife stylefood habithormonal conditionimmune systemchronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: January 15, 2026.

RxHarun
Logo